Case Studies
1 min
Aspire Health Partners BHI-MV
Aspire Health Partners improves assessment, recovery and outcomes while reducing…
Learn More
By Author
![]()
![Uprise Health Icon]()
![Uprise Health Icon]()
![Uprise Health Icon]()
![Uprise Health Icon]()
![Uprise Health Icon]()
Articles
News
2 min
Interview with Dr. Simon Budman, Founder & Chief Strategy Officer at Inflexxion
We recently spoke with Dr. Simon Budman, an internationally known…
Learn More
Blog
2 min
FDA releases steps to ensure safety of abuse-deterrent generic opioids
On March 24, 2016 the Food and Drug Administration (FDA)…
Learn More
Blog
2 min
Relative Abuse of ADF Study presented at the American Pain Society Annual Scientific Meeting
A study conducted by scientists at Inflexxion and Collegium Pharmaceuticals…
Learn More
Blog
2 min
Recently Published: Impact of an Electronic Pain and Opioid Risk Assessment Program: Are There Improvements in Patient Encounters and Clinic Notes?
Recently Published: Impact of an Electronic Pain and Opioid Risk…
Learn More
Blog
2 min
Assessing Abuse Deterrence for New and Low Market Share Products: The absence of evidence is not the evidence of absence
In March, Inflexxion’s Founder and Chief Strategy Officer, Simon Budman,…
Learn More